Carmine N. Stengone, Director of Kiora Pharmaceuticals KPRX, has filed 1 purchase and 3 sales on the open market. Over the past 12 months that comes to a net sale of $120.1K. The latest trade was on 06/10.

CS

CS

Carmine N. Stengone

Director

Company

Kiora Pharmaceuticals KPRX

First filing

23/10/03

Trades

17 trades

Buys / sales

1 / 3

12-month net buying

−$120.1K

Last trade

06/10

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Contineum TherapeuticsCTNM	Open-market sale10b5-1 plan	02/24–02/25	02/26	7,100 sh2 trades	$16.02avg.	$113,742	−32.2%
Contineum TherapeuticsCTNM	Open-market sale10b5-1 plan	02/11	02/13	400 sh	$16.00	$6,400	−2.6%
Kiora PharmaceuticalsKPRX	Open-market buy	24/09/11	24/09/12	1,250 sh	$3.68	$4,600	No record